Chris Raymond - Piper Sandler
Tazeen Ahmad - Bank of America
Malcolm Kuno - JPMorgan
Gena Wang - Barclays
Lydia Erdman - Goldman Sachs
Maury Raycroft - Jefferies
Mehdi Goudarzi - Truist Securities
Yaron Werber - TD Cowen
Yigal Nochomovitz - Citi
Thomas Yip - H.C. Wainwright
Jack Allen - Baird
Joe Schwartz - Leerink Partners
Michael Riad - Morgan Stanley
Kristen Kluska - Cantor Fitzgerald
Dae Gon Ha - Stifel
Good afternoon and welcome to the Ultragenyx Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. At the end of the prepared remarks, you will have opportunity to ask questions during the question-and-answer portion of the call.
It is now my pleasure to turn the call to Joshua Higa, Vice President of Investor Relations.
Joshua Higa
Thank you. We have issued a press release detailing our financial results, which you can find on our website at ultragenyx.com. Joining me on this call are Emil Kakkis, Chief Executive Officer and President; Erik Harris, Chief Commercial Officer; Howard Horn, Chief Financial Officer; and Eric Crombez, Chief Medical Officer.
I'd like to remind everyone that during today's call, we will be making forward-looking statements. These statements are subject to certain risks and uncertainties and our actual results may differ materially. Please refer to the risk factors discussed in our latest SEC filings.
Thanks Josh and good afternoon everyone. This is a great time for Ultragenyx as we successfully completed development work